CAXTON CORP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 86 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$880,000
+19.6%
116,8840.0%1.66%
+67.3%
Q2 2022$736,000
-24.1%
116,8840.0%0.99%
-18.0%
Q1 2022$970,000
+59.8%
116,8840.0%1.21%
+143.1%
Q4 2021$607,000
-35.4%
116,884
-16.9%
0.50%
-34.8%
Q3 2021$939,000
-20.5%
140,622
+1.4%
0.76%
-5.9%
Q2 2021$1,181,000
+41.8%
138,626
+47.3%
0.81%
+49.5%
Q1 2021$833,000
-14.3%
94,083
+19.0%
0.54%
-10.7%
Q4 2020$972,000
+5.8%
79,048
-30.0%
0.61%
-30.0%
Q3 2020$919,000
+16.8%
112,872
+37.7%
0.87%
+4.2%
Q2 2020$787,000
+41.8%
81,983
+0.4%
0.83%
+36.9%
Q1 2020$555,000
-40.0%
81,617
+31.4%
0.61%
-32.0%
Q4 2019$925,000
+45.4%
62,096
+0.1%
0.89%
+24.4%
Q3 2019$636,000
-3.0%
62,015
+0.2%
0.72%
-3.8%
Q2 2019$656,000
-4.8%
61,875
+25.5%
0.74%
+16.6%
Q1 2019$689,000
+55.2%
49,285
+12.8%
0.64%
+18.6%
Q4 2018$444,000
+45.1%
43,709
+71.4%
0.54%
+90.5%
Q3 2018$306,00025,4940.28%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders